Home About UsAims & Objectives Antimicrobial.Resistance Antimicrobial data Bench Protocols Healthcare.Asso.InfecEducational Material News & Updates Meeting & Events Research Activities Useful Links FAQs Contact Us


New Recommendations of ESBL detection in Enterobacteriaceae in CLSI 2010


In CLSI M100 2010, new revised interpretive criteria for cephalosporins (cefazolin, cefotaxime, ceftazidime, and ceftriaxone) and aztreonam susceptibility were established.  Following evaluation of pharmacokinetics-pharmacodynamics (PK-PD) properties and limited clinical data, and on the basis of dosage regimens the breakpoints are revised.


CLSI  M100 S-19 (2009) Sensitive

CLSI M100 S-20 (2010) Sensitive
















 When using the new interpretive criteria, routine ESBL testing is no longer necessary before reporting results (e.g. it is no longer necessary to edit results for cephalosporin, aztreonam, or penicillin from susceptible to resistant. However until laboratories implement the new interpretive criteria, ESBL testing should be routinely performed as described previously. ESBL testing may still be useful for epidemiological and infection control purposes.


Dr Binish Arif







Copyright @ Antimicrobial Resistance Network 2011, All right reserved

Designed & Developed By: Faisal Riaz Malik